ST-segment elevation myocardial infarction (STEMI)

Find all the latest content on STEMI published on this website.

Treating STEMI brings into play a series of clinical and organizational protocols in constant evolution. Today, patients presenting with STEMI are best treated by early reperfusion strategies of which primary PCI is the preferred method. Keep up-to-date on the role of adjunctive pharmacotherapy, advances in imaging techniques and the use of invasive imaging and functional assessment. Tools, devices and techniques as well as complications, such as the different types of vascular access or bleeding risk can be found here as well…

Filtered By
STEMI

538 results

How should I treat a STEMI - A patient's journey - With Angola & Sudan

02 Sep 2022

Watch the replay of #AfricaPCR 2022’s live webinar on STEMI.

How should I treat a STEMI - A patient's journey - With Angola & Sudan

Pretreatment with heparin in patients with ST-segment elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)

01 Sep 2022

Daniele Giacoppo analyses the results of the SCAAR registry which compared patients with STEMI treated by primary PCI in Sweden from January 2008 to December 2016 according to the UFH pretreatment status...

Daniele Giacoppo

Author

Daniele Giacoppo
Pretreatment with heparin in patients with ST-segment elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)

Durable polymer vs. biodegradable polymer DES in patients with ACS undergoing complex PCI: A post hoc analysis of the HOST-REDUCE-POLYTECH-ACS trial

30 Aug 2022

The HOST-REDUCE-POLYTECH-ACS trial was a randomised, parallel-group multicentre trial with a 2x2 factorial design testing two independent hypotheses, one of which was the non-inferiority of durable polymer drug-eluting stents (DP-DES) to biodegradable polymer drug-eluting stents (BP-DES) in patients with ACS. In this post-hoc analysis, the authors...

Nicola Ryan

Reviewer

Nicola Ryan
A post hoc analysis of the HOST-REDUCE-POLYTECH-ACS trial

How should I treat a patient at high-bleeding risk requiring complex distal Left Main PCI for ACS ?

17 Jun 2021

Discover the replay of this webinar on high bleeding risk and complex PCI, with E. Barbato, B. Chevalier, A. Chieffo and T. Cuisset

How should I treat a patient at high-bleeding risk requiring complex PCI?

How to use invasive coronary physiology in ACS patients?

23 Sep 2021

Watch the replay of this webinar on coronary physiology with F. Alfonso, T. Engstrom, T. Keeble and R. Kharbanda

How to use invasive coronary physiology in ACS patients?

A lethal combination. simultaneous inferior and anterior STEMI with aborted sudden cardiac death and cardiogenic shock

11 Aug 2022

View this case of a 60-year-old male with hypertension as a modifiable cardiovascular risk factor. A history of thoracic surgery for a gunshot wound 40 years ago and no cardiovascular history.

Authors :

Juan Guzmán Olea, Miguel Ángel Gómez Pluma, Gabriel Guzmán Olea, Juan Francisco Rodríguez Alvarado, Leticia Arizbeth Hernández Castro, Gonzalo Tolosa Dzul, Carlos Javier González Álvarez, Héctor Hugo Escutia Cuevas, Daniel Iván Pérez Vásquez
A lethal combination. Simultaneous inferior and anterior STEMI with aborted sudden cardiac death and cardiogenic shock

Timing and predictors of definite stent thrombosis in comatose survivors of out-of-hospital cardiac arrest undergoing percutaneous coronary intervention and therapeutic hypothermia (ST-OHCA study)

09 Aug 2022

The ST-OHCA study is a single centre prospective study investigating the incidence, timing and predictors of definite stent thrombosis in comatose survivors of out-of-hospital cardiac arrest (OHCA) undergoing immediate PCI and therapeutic hypothermia.

Nicola Ryan

Reviewer

Nicola Ryan
Timing and predictors of definite stent thrombosis in comatose survivors of out-of-hospital cardiac arrest undergoing percutaneous coronary intervention and therapeutic hypothermia (ST-OHCA study)

Radial versus femoral access in ACS patients undergoing complex PCI is associated with consistent bleeding benefit and no excess of risk

18 Jul 2022

In this paper, the authors investigated the comparative efficacy and safety of TRA versus TFA in ACS patients undergoing complex PCI in the Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and Systemic Implementation of angioX (MATRIX)-Access trial1.

Reviewer

Aaysha Cader

Reviewer

Ali Nazmi Calik
Radial versus femoral access in ACS patients undergoing complex PCI is associated with consistent bleeding benefit and no excess of risk

PCRonline @ ESC Congress 2022: the interventional cardiology perspective!

18 Jul 2022

Stay up to date with what was new and hot in interventional cardiology at the #ESCCongress 2022!

PCRonline @ ESC Congress 2022

Polymer-based versus polymer-free stents in high bleeding risk patients: final 2-year results from Onyx ONE

08 Jun 2022

The results of this study show that at 2-year follow-up HBR patients undergoing PCI with a polymer-based zotarolimus-eluting stent & 1-month DAPT had similar outcomes in terms of both safety & efficacy to those with a polymer-free biolimus A9-coated stent.

Nicola Ryan

Reviewer

Nicola Ryan
Polymer-based versus polymer-free stents in high bleeding risk patients: final 2-year results from Onyx ONE